Home / Share Price Target / Jublpharma
Jubilant Pharmova Share Price Target 2024, 2025, 2026 to 2039 With Charts
Jubilant Pharmova Limited | |||
 | Symbol: JUBLPHARMA | ||
| Price: ₹734.5 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Jubilant Pharmova Brief Company Overview
- 1.1: Company Overview: Jubilant Pharmova Limited
- 1.2: Jubilant Pharmova Financial Performance
- 1.2.1: Is Jubilant Pharmova A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Jubilant Pharmova Share Price Target For 2024
- 2.1.1: Jubilant Pharmova Share Price Target Table For 2024
- 2.1.2: Summary: Jubilant Pharmova Share Price Prediction For 2024
- 2.2: Jubilant Pharmova Share Price Target For 2025
- 2.2.1: Jubilant Pharmova Share Price Target Table For 2025
- 2.2.2: Summary: Jubilant Pharmova Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Jubilant Pharmova Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Jubilant Pharmova Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Jubilant Pharmova Past Performance
Jubilant Pharmova Brief Company Overview
Company Overview: Jubilant Pharmova Limited
Jubilant Pharmova, formerly known as Jubilant Life Sciences, is a life sciences and pharmaceutical giant with a global presence. Since its inception in 1978, Jubilant Pharmova has carved a niche for itself in key markets: India, the Americas, Europe, and internationally.
The company's diverse product portfolio spans radiopharmaceuticals, allergy immunotherapy products, contract manufacturing services for sterile injectables, generic drugs, and proprietary novel drugs. Its comprehensive offerings cater to various therapeutic areas, including oncology, auto-immune diseases, and multispecialty.
Jubilant Pharmova has garnered a reputation for quality and innovation within the industry, actively investing in drug discovery and development services. The company's commitment to providing affordable healthcare solutions has solidified its position as a trusted partner in the healthcare sector.
Advertisement
Jubilant Pharmova Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 11,402.06 Crore | Market valuation of Jubilant Pharmova's shares. |
| Revenue (TTM) | 6,702.9 Crore | Total revenue generated by Jubilant Pharmova over the past twelve months. |
| Net Income (TTM) | +77.09 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 8.7% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 1.14% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +3.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +5.14% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 67.58 | Company's total debt divided by total shareholder equity. |
| Total Debt | 3,663.99 Crore | Sum of Jubilant Pharmova's current & long-term financial obligations. |
| Total Cash | 956.8 Crore | Total amount of liquid funds available to Jubilant Pharmova. |
| Beta | 1.51 | Beta is greater than 1 indicating that the Jubilant Pharmova's price is more volatile than the market. |
Is Jubilant Pharmova A Good Buy For Long Term?
Jubilant Pharmova shows mixed signals for long-term investment. While its recent performance is strong, with 122.58% return over the past year, the company has a significant debt of 3,663.99 Crore. Its low profit margin of 1.14% and declining earnings over the last year also raise concerns. The company's strong revenue growth and positive cash balance suggest potential, but a closer look at the debt burden and profitability is crucial before making a long-term investment decision.
To predict the Jubilant Pharmova's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Jubilant Pharmova Share Price Target For 2024
The line chart displays the monthly closing prices of Jubilant Pharmova with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Jubilant Pharmova shares in 2024, see the table below.
Advertisement
Jubilant Pharmova Share Price Target Table For 2024
| Jubilant Pharmova's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 787.05 (+7.15%) | Price Action: Apr 2018 High |
| 2024 Target 2 | 777.84 (+5.9%) | Price Action: Apr 2017 High |
| 2024 Target 1 | 770.00 (+4.83%) | Price Action: Jun 2024 High |
| Current Price | 734.50 | Jubilant Pharmova's 1 share price as of Mon 01 Jul 2024 |
| Stop Loss 1 | 718.50 (-2.18%) | Price Action: 20 Jun 2024 Low |
| Stop Loss 2 | 711.20 (-3.18%) | Price Action: 18 Jun 2024 Low |
| Stop Loss 3 | 703.43 (-4.24%) | Price Action: Feb 2019 High |
Summary: Jubilant Pharmova Share Price Prediction For 2024
In summary, Jubilant Pharmova has surged by ₹189.05, achieving a notable +34.66% increase from 1st January 2024 to 01 Jul 2024. Our analysis of Jubilant Pharmova for 2024 predicts an additional rise of 4.83% to 7.15% by the end of 2024 with three potential targets T1: 770.00, T2: 777.84, T3: 787.05. Stop Loss at SL1: 718.50, SL2: 711.20, SL3: 703.43.
Jubilant Pharmova has a 52-week high of ₹775.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹318.75, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Jubilant Pharmova.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Jubilant Pharmova Share Price Target For 2025
The line chart displays the monthly closing prices of Jubilant Pharmova with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Jubilant Pharmova shares in 2025, see the table below.
Advertisement
Jubilant Pharmova Share Price Target Table For 2025
| Jubilant Pharmova's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 1090.65 (+48.48%) | Price Action: Chart |
| 2025 Target 2 | 1070.31 (+45.71%) | Price Action: Chart |
| 2025 Target 1 | 1059.71 (+44.27%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 734.50 | Jubilant Pharmova's 1 share price as of Mon 01 Jul 2024 |
| Stop Loss 1 | 660.07 (-10.14%) | Price Action: Nov 2020 High |
| Stop Loss 2 | 651.98 (-11.24%) | Price Action: Apr 2018 Low |
| Stop Loss 3 | 643.31 (-12.42%) | Price Action: Apr 2019 High |
Summary: Jubilant Pharmova Share Price Prediction For 2025
In summary, Jubilant Pharmova has surged by ₹189.05, achieving a notable +34.66% increase from 1st January 2024 to 01 Jul 2024. Our analysis of Jubilant Pharmova for 2025 predicts an additional rise of 44.27% to 48.48% by the end of 2025 with three potential targets T1: 1059.71, T2: 1070.31, T3: 1090.65. Stop Loss at SL1: 660.07, SL2: 651.98, SL3: 643.31.
Jubilant Pharmova has a All-Time high of ₹1039.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹318.75, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Jubilant Pharmova, we have created a specific page for that check here: Jubilant Pharmova Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Jubilant Pharmova Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Jubilant Pharmova share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 14.99% over the next 15 years.
For complete year by year Jubilant Pharmova long term share price target from 2024, 2025 to 2039 check the below table.
Jubilant Pharmova Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Jubilant Pharmova Target | YoY Change % |
|---|---|---|
| 2024 | ₹734.5 | [Current Price] |
| 2024 | ₹807.81 | 9.98% |
| 2025 | ₹1,174.7 | 45.41% |
| 2026 | ₹1,547.61 | 31.74% |
| 2027 | ₹2,079.32 | 34.35% |
| 2028 | ₹2,110.48 | 1.49% |
| 2029 | ₹2,331.28 | 10.46% |
| 2030 | ₹2,783.36 | 19.39% |
| 2031 | ₹3,211.28 | 15.37% |
| 2032 | ₹3,919.04 | 22.03% |
| 2033 | ₹3,697.02 | -5.67% |
| 2034 | ₹3,854.76 | 4.26% |
| 2035 | ₹4,392.01 | 13.93% |
| 2036 | ₹4,874.95 | 10.99% |
| 2037 | ₹5,758.76 | 18.12% |
| 2038 | ₹5,283.56 | -8.26% |
| 2039 | ₹5,706.79 | 8.01% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Jubilant Pharmova Past Performance
- In 1993, Jubilant Pharmova opening price was ₹13.39
- As of Mon 01 Jul 2024 the price stands at ₹734.5.
- This represents a Compound Annual Growth Rate (CAGR) of 13.33%.
- In 31 years, an investment of 10,000 would have become ₹5.48 Lakh.
As we wrap up, we hope you like our study on Jubilant Pharmova share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Jubilant Pharmova Share Price History
- Jubilant Pharmova Price Target Tomorrow
- Jubilant Pharmova Dividend History
- Jubilant Pharmova Bonus History
- Jubilant Pharmova Split History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
